Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,217 across all filing types
Latest filing 2021-09-15 Regulatory Filings
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions that the company issued a press release announcing preliminary unaudited revenue for a recent month, and the press release is furnished as an exhibit. There are no detailed financial statements or comprehensive financial analysis included in the text. The document is short (3389 characters) and primarily serves as an announcement of the press release rather than the full earnings report itself. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it does not contain the full financial report or detailed financial data but is a current report filing with the SEC.
2021-09-15 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and states that the company issued a press release announcing preliminary unaudited revenue for the month ended July 31, 2021. It also notes that the press release is furnished as an exhibit to this Form 8-K. The document does not contain detailed financial statements or comprehensive financial analysis but rather a brief announcement of preliminary financial results. According to the filing definitions, an initial announcement of quarterly or periodical financial results (key highlights only) corresponds to an Earnings Release (ER). The document length is 3378 characters, which is relatively short and consistent with an earnings release announcement rather than a full report. Therefore, the appropriate classification is Earnings Release (ER).
2021-08-10 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-05 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-05 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 registration statement filed with the SEC by Pacira BioSciences, Inc. It relates to the registration of additional shares under the company's stock incentive plan. Form S-8 is a specific SEC filing used to register securities to be offered to employees under employee benefit plans. The document includes details about the securities, indemnification provisions, and references to other SEC filings but does not contain financial statements or earnings data. It is not an annual report, earnings release, or any other financial report type. Instead, it is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a certification letter but a full registration statement, which fits under RNS as a general regulatory filing category for such SEC forms that do not fit other categories.
2021-08-03 English
10-Q - PCRX - 6.30.2021
Interim / Quarterly Report Q2 2021
2021-08-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.